Delivery Order 75N95021D00026-75N95024F00001

The National Institute on Drug Abuse awarded a firm fixed-price delivery order valued at $258,274 to IIT Research Institute (IITRI) on March 1, 2024, for Management and Operations Support under Performance Area 1. The contract is scheduled for completion by February 28, 2027, and will be performed in Chicago, Illinois. This delivery order represents work conducted under one of IITRI's larger indefinite delivery/indefinite quantity contract vehicles with the National Institutes of Health. No set-aside designation was used in this award, indicating it was competed on a full and open basis. IITRI is a non-profit contract research organization and wholly-owned subsidiary of Illinois Institute of Technology, specializing in preclinical drug development services and research support across multiple scientific and technical domains for federal agencies.

IITRI's parent organization, Illinois Institute of Technology, maintains substantial IDIQ contract vehicles totaling hundreds of millions of dollars across the NIH ecosystem, including contracts with the National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences, National Cancer Institute, and National Institute of Neurological Disorders and Stroke. These vehicles support preclinical research services including toxicology studies, safety evaluations, pharmacokinetic analyses, and drug efficacy assessments. The current delivery order continues IITRI's established role as a critical resource for federal agencies conducting early-stage drug development and safety evaluation research supporting investigational new drug applications across cancer, neurological, infectious disease, and other therapeutic areas.